GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a significant focus in therapeutic studies, largely due to its remarkable impact on controlling diseases such as second type diabetes and weight gain. Ongoing studies have demonstrated that more than glucose management, GLP-1 medications offer promise for heart well-bein